Erratum: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))

Marie R. Webster, Mitchell E. Fane, Gretchen M. Alicea, Subhasree Basu, Andrew V. Kossenkov, Gloria E. Marino, Stephen M. Douglass, Amanpreet Kaur, Brett L. Ecker, Keerthana Gnanapradeepan, Abibatou Ndoye, Curtis Kugel, Alexander Valiga, Jessica Palmer, Qin Liu, Xiaowei Xu, Jessicamarie Morris, Xiangfan Yin, Hong Wu, Wei XuCathy Zheng, Giorgos C. Karakousis, Ravi K. Amaravadi, Tara C. Mitchell, Filipe V. Almeida, Min Xiao, Vito W. Rebecca, Ying Jie Wang, Lynn M. Schuchter, Meenhard Herlyn, Maureen E. Murphy, Ashani T. Weeraratna

Research output: Contribution to journalComment/debatepeer-review

Abstract

(Molecular Cell 77, 633–644.e1–e5; February 6, 2020) Due to a miscommunication, the name Tara Miller was inadvertently added to the author list. This has since been amended, and the name now appears correctly online and in print as part of an affiliation, the Tara Miller Melanoma Center at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. The authors regret this error.

Original languageEnglish (US)
Pages (from-to)681
Number of pages1
JournalMolecular cell
Volume77
Issue number3
DOIs
StatePublished - Feb 6 2020

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Erratum: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009))'. Together they form a unique fingerprint.

Cite this